Dosing Regimen Individualization Body Size Variability in Body Size Does one size fit all ? If body size is outside the range  25% of normal (for 70.

Slides:



Advertisements
Similar presentations
PHARMACOKINETIC MODELS
Advertisements

Body Composition Chapter 6.
Selected Clinical Calculations
Statistics Problems and Review. Types of Statistics Descriptive Used to measure a trait or characteristic without generalizing beyond the group: used.
Dosage Regimen Design in Patients with Renal Insufficiency Cont’d Pharmacy 732 Winter, 2001.
Nonlinear pharmacokinetics
Introduction to Prescribing - Part 2 3 rd year Medical Students.
Evaluation of the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault (C-G) formulas in the Calvert equation for Carboplatin Dosing Whitney.
Dosage Adjustments for Aminoglycosides in Obese Patients Dennis Mungall, Pharm.D. Associate Professor, Pharmacy Practice Director, NTPD OSU,College of.
Multiple Regression Analysis The principles of Simple Regression Analysis can be extended to two or more explanatory variables. With two explanatory variables.
Obesity, Exercise and Weight Control HFIT 325 Exercise Physiology American University Reference book: Power’s 5 th Edition.
Dosing Regimen Design Infusion regimen.
INTRAVENOUS INFUSION.
Lucile Packard Children’s Hospital
Dosing Regimen Individualization Age. Subcategories Newborn1-7 d Neonate8 d – 2 mo Infant2 mo – 1 yr Child1 – 12 yr Adolescent12 – 20 yr Adult20 – 70.
VM 8314 Dr. Jeff Wilcke Pharmacokinetic Modeling (describing what happens)
CLEARANCE CONCEPTS Text: Applied Biopharm. & PK
Pharmacokinetics Introduction
Calculation.
Multiple Dosing: Intermittent or multiple dose regimen
 BSA (m 2 ) = √ Ht(in) X wt (lb) 3131 Ht (cm) X wt (kg) 3600 Mosteller,RD " Simplified Calculation of Body Surface Area", N Engl J Med 1987, 317 (17):
PHARMACOKINETIC MODELS
VARIABILITY IN PHARMACOKINETICS & PATIENT RESPONSE Dr. Mohd B. Makmor Bakry, Ph.D., RPh Senior Lecturer in Clinical Pharmacy Universiti Kebangsaan Malaysia.
Cystic Fibrosis Patients are Pharmacokinetically Comparable to Healthy Volunteers J. Bulitta 1, S. B. Duffull 2, M. Kinzig-Schippers 1, U. Holzgrabe 3,
PCB 3043L - General Ecology Data Analysis. PCB 3043L - General Ecology Data Analysis.
Clearance Determinations Arthur G. Roberts. Routes of Elimination.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
INTRODUCTION CLINICAL PHARMACOKINETICS
Renal Physiology and Function Part II Renal Function Tests
Pharmacokinetics of Vancomycin in Adult Oncology Patients Hadeel Al-Kofide MS.c; Iman Zaghloul PhD; and Lamya Al-Naim PharmD Department of Clinical Pharmacy,
Clinical Pharmacokinetics of Procainamide Dr. Muslim Suardi Faculty of Pharmacy University of Andalas 2013.
Lecture 2 Clearance, maintenance dose and AUC
Pharmacokinetics: Digoxin Allie Punke
P AEDIATRICS EMC IV A DULT VERSUS CHILD Anatomy upper and lower airway anatomy. less compliant ventricles in the myocardium. larger skin surface.
Lecture 29: Calculate GFR Infants – Normal: 2.0 mg/L (0.2 mg/dL) – Kidney Disease: >20.0 mg/L (2 mg/dL) Adults Males: 6-12 mg/L ( mg/dL) Females:
PCB 3043L - General Ecology Data Analysis Organizing an ecological study What is the aim of the study? What is the main question being asked? What are.
Anticonvulsants: Phenytoin
How to Calculate Your Body Mass Index (BMI)
Adult and Pediatric Dosages Based on Body Surface Area
Vancomycin administered by continuous infusion should be dosed according to clearance and not based on the patient's body weight P. M. Tulkens1, P. Wallemacq1.
Allie punke pharmcokinetics Allie punke
Pharmacokinetics of Vancomycin in Adult Oncology Patients
Lecture-8 Biopharmaceutics
Updates on Policy #38 Addressing Subjects with Non-Average Heights and Weights 2017 SWOG Fall Meeting BOG Siu Fun Wong, PharmD Co-Chair, Pharmaceutical.
Pharmacokinetic Modeling (describing what happens)
Dosing considerations in obese children
Net metabolic rate of walking at 1. 5 m/s vs
29 Vancomycin Administered by Continuous Infusion
Dosing Regimen Concepts: 2-C, MM, Individualization principles
(A) Simulation of propofol effect-site concentrations (Ce) that result from a bolus (2 mg/kg) and 1-hour infusion (150 mcg/kg/min) for a 53-year-old 155-cm.
Predictions of scaled weight based on lean body mass, fat-free mass,13 modified fat-free mass,16,17 ideal body weight, and pharmacokinetic (PK) mass14,15.
Quantitative Pharmacokinetics
Renal Pharmacy Group Beginners Lectures 2018
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Manjunath P. Pai  Advances in Chronic Kidney Disease 
Allie Punke Pharmacokinetics Allie Punke
Nutritional assessment in hospitalized patients
Hawler Medical University
Table 1. General Characteristics of the Study Subjects
A.R. Absalom, V. Mani, T. De Smet, M.M.R. F. Struys 
Dose adjustment of anaesthetics in the morbidly obese
M Carron, S Guzzinati, C Ori  British Journal of Anaesthesia 
Clinical Pharmacokinetics
Distance – Time Graphs Time is usually the independent variable (plotted on the x-axis) Distance is usually the dependent variable (plotted on the y-axis)
F.H. Engbers, N Sutcliffe, G Kenny, S Schraag 
REFERENCE: APPLIED CLINICAL Slideshow by: lecturer HADEEL DELMAN
Many anticancer drugs are dosed according to body surface area (BSA), but they are dose adjusted according to measures of absolute kidney function (i.e.,
Two to 20 years: female patients, continued.
Presentation transcript:

Dosing Regimen Individualization Body Size

Variability in Body Size Does one size fit all ? If body size is outside the range  25% of normal (for 70 kg, less than 52.5 kg [115 lb] or greater than 87.5 kg [193 lb]), an adjustment in the DR should be considered.

LD: Proportional to V How to make the adjustment depends on the distribution characteristics of the drug: Polar and distributes in total body water: LD = LD usual x (W/70) If patient is obese, adipose tissue has little water, so base LD on what the patient’s weight would be if they were normal weight.

Adjustment for W in the obese patient. 1. Calculate lean body mass (LBM) and use 55 kg as the normal LBM: LD = LD usual x (LBM/55) LBM male = 1.10 W (W/H) 2 W, kg; H, cm LBM female = 1.07 W (W/H) 2 2. Calculate ideal body weight (IBW) and use 70 kg as the normal IBW: LD = LD usual x (IBW/70) IBW male = (H) 2 W, kg; H, cm IBW female = (H) 2

Fat-soluble drugs Use the same guideline as for polar drug. Due to slow distribution into adipose tissue, only load the nonadipose tissue and let the maintenance dose fill the adipose tissue.

Drugs that distribute only into ECW LD should be based upon the BSA of the patient. No special allowance is needed for obesity. LD = LD usual x (BSA/1.87) BSA (m 2 ) = * H * W H, cm; W, kg

Maintenance Dose f up CL int,u Q H Q R GFR CL RS,int Key Physiological Variables:

Allometric Equation For many physiological variables, the allometric equation describes their relationship to body weight, W, among a group of animals of different body weight: liver weight (kg) = W W, kg log W log CL a = W = 1 b = slope

D M adjustment: b value (D M /  ) new = (D M /  ) std X [W/70] 0.75 For W = 35 kg [35/70] 0.75 = 0.60 FDM/KoFDM/Ko unusual CL unusual CL usual FDM/KoFDM/Ko usual = CL new = CL std X [W/70] 0.75

Drug Clearance: b values n = 110 mean = 0.77  0.19 median = 0.75 T.-M. Hu, W.L. Hayton. AAPS PharmSci 2001; 3(4) article 29 (

slope = b = 0.74

D M adjustment For all but renally eliminated drugs: (D M /  ) new = (D M /  ) std X [W/70] 0.75 For W = 35 kg [35/70] 0.75 = 0.60 [35/70] 0.67 = 0.63 For renally eliminated drugs: (D M /  ) new = (D M /  ) std X [W/70] 0.67

Allometric Equation Approach Uses CL and V values in at least two subject groups that have different body weights. Example: Cefotiam in Sumo Wrestlers Height [cm] Weight [kg] V ss [L] CL [L/h] t 1/2 [h] Sumo Control K Chiba et al., Antimicrob. Agents Chemother. 33:1188,1989.

What is a Sumo Wrestler ?

DR for Sumo Wrestler Usual regimen: 2 g stat (LD) and 1 g q 6 h (D M /  ). Calculate b value for V ss and for CL V ss = aW b 30.2 = a 124 b & 17.9 = a 58 b (30.2/17.9) = (124/58) b a values cancel b = ln (30.2/17.9) / ln (124/58) = LD sumo = (124/70) X 2 g = 2.96 g

DR for Sumo Wrestler, cont. Calculate b value for CL CL = aW b 38.3 = a 124 b & 23.5 = a 58 b (38.3/23.5) = (124/58) b b = ln (38.3/23.5) / ln (124/58) = DM sumo = (124/70) X 1 g = 1.44 g